84,926 Verizon (NYSE: VZ) RSUs granted to EVP Kyle Malady

Rhea-AI Filing Summary

Verizon Communications executive Kyle Malady reported a grant of 84,926 special restricted stock units (RSUs) under a 2026 award. The derivative award was recorded at a price of $0 per unit, with Malady shown as holding 84,926 derivative securities directly after the transaction.

Each RSU represents the right to receive one share of Verizon common stock, plus accrued dividends, on the payment date tied to vesting. According to the award terms, these RSUs are scheduled to vest on December 31, 2027, providing equity-based compensation to Malady in his role as EVP and Group CEO–VZ Business.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Malady Kyle

(Last) (First) (Middle)

VERIZON COMMUNICATIONS INC.

1095 AVENUE OF THE AMERICAS

(Street)

NEW YORK NY 10036

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERIZON COMMUNICATIONS INC [ VZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP and Group CEO-VZ Business

3. Date of Earliest Transaction (Month/Day/Year)
02/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Special Restricted Stock Units - 2026 Award	(1)	02/04/2026		A		84,926		(1)	(1)	Common Stock	84,926	$0	84,926	D

Explanation of Responses:

1. Each Restricted Stock Unit (RSU) represents the right to receive one share of common stock, plus accrued dividends, on the payment date with respect to the date that the RSU vests. Subject to the terms of the RSU Agreement, the RSUs will vest on December 31, 2027.

Remarks:

	William L. Horton, Jr., Attorney-in-fact for Kyle Malady	02/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Verizon (VZ) report for Kyle Malady?

Verizon reported that EVP and Group CEO–VZ Business Kyle Malady received 84,926 special restricted stock units as a 2026 award. The Form 4 shows this as an acquisition of derivative securities at a stated price of $0 per unit, held directly.

How many Verizon RSUs were granted to Kyle Malady in the 2026 award?

Kyle Malady was granted 84,926 special restricted stock units in the 2026 award. The filing shows 84,926 derivative securities acquired and 84,926 derivative securities beneficially owned directly following the transaction, all tied to Verizon common stock underlying the RSUs.

When do Kyle Malady’s 2026 Verizon RSUs vest?

The 2026 special restricted stock units granted to Kyle Malady are scheduled to vest on December 31, 2027. Vesting means he becomes entitled to receive the related Verizon common shares, plus accrued dividends, according to the RSU agreement terms described in the footnote.

What does each Verizon RSU granted to Kyle Malady represent?

Each restricted stock unit represents the right to receive one share of Verizon common stock, plus accrued dividends, on the payment date associated with vesting. This structure aligns Malady’s compensation with Verizon’s equity performance over the vesting period ending December 31, 2027.

Is Kyle Malady’s Verizon RSU award reported as a direct or indirect holding?

The Form 4 reports Kyle Malady’s 84,926 special restricted stock units as a direct holding. The ownership form column in Table II is marked “D” for direct, and no nature of indirect beneficial ownership is listed for this derivative securities award.

What role does Kyle Malady hold at Verizon (VZ) in this Form 4?

In this Form 4, Kyle Malady is identified as an officer of Verizon, serving as EVP and Group CEO–VZ Business. The relationship section confirms he is not a director or 10% owner, but an executive receiving equity compensation through restricted stock units.